期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Predictive factors for early clinical response in community-onset Escherichia coli urinary tract infection and effects of initial antibiotic treatment on early clinical response
1
作者 Young Jun Kim Jeong-Mi Lee Jae-Hoon Lee 《World Journal of Clinical Cases》 SCIE 2020年第19期4342-4348,共7页
BACKGROUND Urinary tract infection(UTI)is a common disease.It often requires hospitalization,and severe presentations,including sepsis and other complications,have a mortality rate of 6.7%-8.7%.AIM To evaluate the pre... BACKGROUND Urinary tract infection(UTI)is a common disease.It often requires hospitalization,and severe presentations,including sepsis and other complications,have a mortality rate of 6.7%-8.7%.AIM To evaluate the predictive factors for early clinical response and effects of initial antibiotic therapy on early clinical response in community-onset Escherichia coli(E.coli)urinary tract infections(UTIs).METHODS This retrospective study was conducted at Wonkwang University Hospital in South Korea between January 2011 and December 2017.Hospitalized patients(aged>18 years)who were diagnosed with community-onset E.coli UTI were enrolled in this study.RESULTS A total of 511 hospitalized patients were included.66.1%of the patients had an early clinical response.The mean length of hospital stay in patients with an early clinical response were each 4.3 d shorter than in patients without an early clinical response.In the multiple regression analysis,initial appropriate antibiotic therapy(OR=2.449,P=0.006),extended-spectrum(3-lactamase(ESBL)-producing E.coli(OR=2.112,P=0.044),improper use of broad-spectrum antimicrobials(OR=0.411,P=0.006),and a stay in a healthcare facility before admission(OR=0.562,P=0.033)were the factors associated with an early clinical response.Initial broadspectrum antibiotic therapy was not associated with an early clinical response.CONCLUSION ESBL producing E.coli,and the type of residence before hospital admission were the factors associated with an early clinical response.Appropriateness of initial antibiotic therapy was a predictive factor for an early clinical response,but broadspectrum of initial antibiotic therapy did not impact early clinical response. 展开更多
关键词 Escherichia coli Urinary tract infections ADULT community acquired infections
下载PDF
2002—2003年中国革兰阴性细菌耐药性监测研究 被引量:296
2
作者 李家泰 李耘 +1 位作者 齐慧敏 代表中国细菌耐药监测研究组 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第1期19-29,共11页
目的 监测我国不同地区 14家医院 31个研究病房的医院获得感染 (HAI)与社区获得感染 (CAI)患者中分离的革兰阴性细菌耐药状况。方法 按原设计方案对 14家医院从 2 0 0 2年 7月1日至 2 0 0 3年 6月 30日分离的 10 91株革兰阴性菌 ,采... 目的 监测我国不同地区 14家医院 31个研究病房的医院获得感染 (HAI)与社区获得感染 (CAI)患者中分离的革兰阴性细菌耐药状况。方法 按原设计方案对 14家医院从 2 0 0 2年 7月1日至 2 0 0 3年 6月 30日分离的 10 91株革兰阴性菌 ,采用国际标准平皿二倍稀释法进行体外敏感试验 ,测得MIC50 、MIC90 表示抗菌药物的抗菌活性 ,并按 2 0 0 2年美国临床实验标准委员会 (NCCLS)指导原则的标准计算细菌对抗菌药物的耐药率 (R) %、中介率 (I) %和敏感率 (S) %。结果 碳青霉烯类仍是对革兰阴性杆菌 (除外嗜麦芽窄食单胞菌与黄杆菌 ,该 2种非发酵阴性杆菌对碳青霉烯类高度耐药 )抗菌作用最强的一类抗生素。头孢哌酮 /舒巴坦、哌拉西林 /他唑巴坦、头孢吡肟和新氟喹诺酮类 ,如加替沙星、莫西沙星、左氧沙星对革兰阴性杆菌亦有很好的抗菌活性 ,但仍有 5 0 %~ 6 0 %的大肠埃希菌对氟喹诺酮类耐药。从HAI患者分离的革兰阴性杆菌耐药率比从CAI患者分离的相应阴性杆菌的耐药率要高 1 5倍以上。结论 头孢哌酮 /舒巴坦、哌拉西林 /他佐巴坦和加替沙星对非发酵阴性杆菌的抗菌谱较广 ,抗菌作用也较好 ,是值得注意的抗非发酵菌抗菌药物。我们从 2 0 0 2— 2 0 0 3年度所得的监测结果与 2 0 0 0— 2 0 0 展开更多
关键词 革兰阴性细菌 革兰阴性杆菌 耐药率 抗菌药物 HAI 头孢哌酮/舒巴坦 加替沙星 cai 结论 指导原则
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部